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ABSTRACT 
Contractile myoepithelial cells dominate the basal layer of the mammary epithelium and are 
considered to be differentiated cells. However, we observe that up to 54% of single basal 
cells can form colonies when seeded into adherent culture in the presence of agents that 
disrupt acin-myosin interactions, and on average, 65% of the single-cell-derived basal 
colonies can repopulate a mammary gland when transplanted in vivo. This indicates that a 
high proportion of basal myoepithelial cells can give rise to a mammary repopulating unit 
(MRU). We demonstrate that myoepithelial cells, flow-sorted using 2 independent 
myoepithelial-specific reporter strategies, have MRU capacity. Using an inducible lineage 
tracing approach we follow the progeny of α-smooth muscle actin-expressing myoepithelial 
cells and show that they function as long-lived lineage-restricted stem cells in the virgin state 
and during pregnancy. 
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INTRODUCTION 
The mammary epithelium is composed of an outer layer of basal cells that reside on the 
basement membrane and an inner layer of luminal cells, and collectively these cells are 
organised as a series of branched ducts that drain alveolar structures during pregnancy. The 
basal cell layer is composed predominantly of contractile myoepithelial cells, a cell type that 
has both epithelial and smooth muscle cells features and function to eject milk from the 
lactating mammary gland1,2. Electron microscopy studies have shown that the basal cell 
layer also contains a subpopulation of small light cells (SLCs) that appear relatively 
undifferentiated and have been hypothesised to represent mammary stem cells3,4. The 
identity of mammary stem cells is controversial. Previous studies have demonstrated that a 
rare subset of basal cells have the ability to generate ductal-lobular outgrowths when 
transplanted into cleared mammary fat pads of recipient mice5-7. These engrafting cells are 
termed mammary repopulating units, or MRUs. However, it has not been possible to resolve 
these cells from the myoepithelial cells that constitute most of the basal cell compartment. 
Subsequent studies using a lineage tracing approach have demonstrated that the luminal 
and basal compartments of the mammary epithelium are maintained by their own lineage-
restricted stem cells, and it was suggested that the multilineage potential of the MRUs is an 
artefact of the transplantation assay8-10. However, a more recent report has challenged the 
existence of lineage-restricted stem cells, and has reported that the mammary epithelium is 
maintained by a multilineage basal stem cell11, although these two stem cell models need 
not be mutually exclusive.  
 
In this manuscript, we demonstrate that a high proportion of basal cells, most of which are 
myoepithelial cells, can acquire MRU potential when cultured in the presence of a Rho 
protein kinase inhibitor. We also demonstrate, through the use of two different myoepithelial-
reporter transgenic mouse strains, that freshly isolated myoepithelial cells have MRU 
capacity. The stem cell nature of myoepithelial cells was further confirmed in lineage tracing 
experiments using Acta2-Cre-ERT2;Rosa26LacZ mice, which demonstrated that 
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myoepithelial cell-derived clones expand within the basal cell layer during pubertal 
development and pregnancy, survive through involution and contribute to the basal layer of 
ducts and alveoli in multiple pregnancies.  
 
RESULTS 
The vast majority of basal cells are non-dividing myoepithelial cells 
The basal cell population can be isolated to high purity using flow cytometry based on the 
differential expression of epithelial cell adhesion molecule (EpCAM) and alpha 6 integrin 
(CD49f)12 (Fig. 1a, Supplementary Fig. 1a). The basal population can be subdivided into 
EpCAMhigh (upper 20% of the population) and EpCAMlow (lower 80%) subpopulations (Fig. 
1a), with the former containing a ~5-fold higher frequency of MRUs and ~60% of all MRUs 
(Fig. 1e). The vast majority of basal cells appear to be myoepithelial cells since ~97% of 
double-sorted basal cells expressed the myoepithelial marker alpha smooth muscle actin13 
(αSMA) (Fig. 1b). By contrast, only 0.33% (±0.13) of double-sorted luminal cells expressed 
αSMA (n=4). There was no difference in the proportion of αSMA+ cells between basal 
EpCAMhigh and EpCAMlow cells; nor was there any difference in the level of myoepithelial-
associated gene transcripts (Acta2 and Myh11) or in the level of smooth muscle actin protein 
between these subpopulations (Fig. 1c, d). We hypothesised that dividing cells may express 
higher levels of EpCAM and thus may be enriched within the basal EpCAMhigh 
subpopulation. After injecting mice with a synthetic nucleoside (either 5-iodo-2’-deoxyuridine 
(IdU) or 5-bromo-2’-deoxyuridine (BrdU)), we observed that the basal EpCAMhigh cell 
subpopulation contained a 6-fold higher frequency of nucleoside+ cells compared to 
EpCAMlow cells (Fig. 1f). When corrected for population size, the majority (66%) of 
nucleoside+ cells localised within the basal EpCAMhigh subpopulation (Fig. 1g). When freshly 
dissociated mammary cells were stained with the DNA binding dye, Hoechst 33342 to 
identify cells within the S/G2/M phases of the cell cycle (Supplementary Fig. 2), we observed 
that the basal EpCAMhigh subpopulation was enriched 8-fold for S/G2/M cells compared to 
the EpCAMlow subpopulation (Supplementary Fig. 3a). The majority (65%) of S/G2/M cells 
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localised within the basal EpCAMhigh subpopulation (Supplementary Fig. 3b). Hoechst4n cells 
were visually confirmed as proliferating cells and not merely cell clumps (Supplementary Fig. 
3c). Since the frequency and distribution of MRUs correlated with those of nucleoside+ cells 
within the basal cell population, we hypothesised that basal cell proliferation status may 
influence their mammary repopulating capacity. To test this, we assessed the MRU and 
progenitor capacity of freshly isolated G0/G1 and S/G2/M basal cells and observed that the 
S/G2/M basal cells had a significantly higher MRU frequency and colony forming efficiency 
(CFE), although when accounting for cell population size, 81% of MRUs were in G0/G1 
phase (Supplementary Fig. 3d, e).  
 
Short-term culture increases MRU frequency and number 
To determine if basal cells had proliferative capacity in vitro, flow-sorted basal cells were 
seeded at low density in FAD media14 together with irradiated feeder cells and allowed to 
form colonies over 7 days. In the absence of the Rho-kinase inhibitor, Y-27632, the colony-
forming efficiency (CFE) of basal cells was 5.2±1.5%, but this increased to 29.1±1.5% when 
Y-26732 was included in the culture media (n=3). The observed CFEs is an underestimate 
of the true CFE since we observe a ~50% reduction in mammary epithelial cell CFE due to 
cell toxicity caused by DAPI (4', 6-diamidino-2-phenylindole) and the antibodies used for 
flow-sorting (Supplementary Fig. 1b). These basal cultures in the presence of Y-26732 could 
be maintained for 13 passages (~140 cell divisions) before failing to form colonies. Since 
basal cells showed extensive proliferative capacity in vitro, we sought to determine whether 
MRUs were maintained during culture. To test this, we transplanted non-cultured and 7-day-
cultured mouse basal cells at limiting dilutions into cleared fat pads of C57BL/6J mice. 
Remarkably, there was a ~460-fold expansion in MRU numbers during this 7-day culture 
period (Fig. 2a). The ductal-lobular outgrowths generated from these 7-day cultured MRUs 
were morphologically indistinguishable from those generated from freshly isolated basal cells 
(Fig. 2b).  
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The majority of single-cell-derived basal colonies can repopulate a mammary gland 
To determine whether the rapid MRU expansion that we observed is driven by myoepithelial 
cells acquiring MRU activity or expansion of existing MRUs, single-basal-cell-derived, 7-day-
old colonies were transplanted into cleared fat pads. Mammary glands from C57BL/6J.CBA-
Tg(Actb-EGFP) mice were used for donor tissue and since transgene-free mice of the same 
strain were not available, we used NOD/SCID IL2Rγc-/- pups as recipients. A single basal 
cell was flow-sorted into each well of a 96-well dish and each well was visually confirmed to 
contain a single GFP+ cell. It was observed that 54±4% of EpCAMhigh and 30±5% EpCAMlow 
cells could form a colony after 7 days of culture in the presence of the Rho-kinase inhibitor 
Y-27632. Individual colonies were trypsinised and transplanted into separate cleared 
mammary fat pads. Approximately 83% of colonies derived from a basal EpCAMhigh cell 
repopulated a mammary gland and 61% of the colonies derived from basal EpCAMlow cells 
engrafted, demonstrating that de novo acquisition of MRU potential occurred during culture 
(Fig. 3a). The engraftments from single-cell-derived basal colonies expressed luminal (Mucin 
1) and basal (CK14 and αSMA) markers and produced β-casein during pregnancy (Fig. 3b). 
In addition, the primary outgrowths were capable of forming secondary engraftments when 
dissociated and re-transplanted into cleared fat pads, demonstrating that MRU self-renewal 
had occurred (Supplementary Table 1). 
 
Cytoskeletal remodelling and inhibition of TGFβ significantly influence basal colony 
formation  
In order to understand the molecular changes that might be responsible for MRU expansion, 
we performed gene expression profiling of non-cultured, 1-day-cultured and 7-day-cultured 
basal cells. There were ~12,000 differentially expressed genes (DEGs), at FDR<0.01, 
between non-cultured basal cells compared to 1 or 7-day-cultured basal cells and ~7,000 
DEGs between 1-day and 7-day cultured basal cells. Pathway enrichment analysis of the 
microarray data using MetaCore (GeneGo Inc.) demonstrated that cytoskeletal remodelling 
and TGFβ pathways were significantly downregulated during culture (Supplementary Fig. 
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4a). Addition of TGFβ1 protein to FAD media significantly reduced basal cell CFE and this 
was rescued by adding an inhibitor of the TGFβ receptor, SB 43154215, to the media 
(Supplementary Fig. 4b). To investigate the effect of cytoskeletal remodelling on basal cell 
colony formation, we used small molecule inhibitors to modulate actin dynamics. Latrunculin 
B and cytochalasin D, which inhibit filamentous (F)-actin polymerisation and increase the 
free pool of globular (G)-actin monomers16,17, significantly increased basal cell CFE 
(Supplementary Fig. 4c). However, at a higher concentration (250 nM), cytochalasin D 
completely inhibits basal colony formation in the presence of Y-27632 (Supplementary Fig. 
4c). Jasplakinolide, which stabilises F-actin18, significantly reduced basal colony formation in 
the presence of Y-27632 (Supplementary Fig. 4c). To confirm that Rho kinase inhibition 
increases basal cell CFE we added a different Rho kinase inhibitor, H115219, to FAD media 
and observed that it significantly increased basal cell CFE to a similar level to that observed 
with Y-27632 (Supplementary Fig. 4d). Rho kinase inhibition has been shown to reduce 
apoptosis of dissociated embryonic stem cells by preventing actomyosin contraction20,21. To 
test whether the same mechanism was operating in mammary basal cells, we added a 
myosin II inhibitor, blebbistatin22, to FAD media and observed that it significantly increased 
basal colony formation to a similar level to that obtained with the Rho kinase inhibitors 
(Supplementary Fig. 4d). The results show that actin cytoskeleton remodelling and 
downregulation of TGFβ signalling permit a high proportion of basal cells to form colonies.  
 
Myoepithelial cells have mammary repopulating capacity and can undergo clonal 
expansion in vivo  
To directly test the proliferative and MRU capacity of freshly isolated, non-cultured 
myoepithelial cells, we utilised two independent smooth muscle-specific reporter strategies 
(Acta2-GFP and Myh11-Cre-GFP;Rosa26LacZ) to isolate and sort a pure population of 
myoepithelial cells. Both α-smooth muscle actin (encoded by Acta2) and smooth muscle 
myosin (encoded by Myh11) are functional markers of myoepithelial cells and enhance 
contractile force generation during lactation23. Sections through the mammary glands of 
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Acta2-GFP transgenic mice showed colocalisation of GFP and αSMA expression (Fig. 4a). 
Using flow cytometry, we observed basal αSMA+ and basal αSMA- cells (Fig. 4b, 
Supplementary Fig. 5a-c). These SMA- basal cells are epithelial in nature since 82±4% of 
these cells express CK14 or CK5 (Supplementary Fig. 5d). Approximately 30% of basal 
αSMA+ cells had colony forming potential, but surprisingly less than 1% of basal αSMA- cells 
could form colonies (Fig. 4c). To assess the MRU capacity of myoepithelial cells, basal 
αSMA+ cells were transplanted at limiting dilution into cleared fat pads of C57BL/6J mice and 
~1% of basal αSMA+ cells had repopulating capacity (Fig. 4d). Basal αSMA- cells were 
transplanted at cell doses proportion to their population size but no engraftments were 
observed despite transplanting a total of 860 cells. Engraftments derived from basal αSMA+ 
cells were dissociated and non-sorted cells were re-transplanted at limiting dilution into 
cleared fat pads. Secondary engraftments were generated demonstrating that MRU self-
renewal had occurred (Supplementary Fig. 5e). We also utilised a Myh11-Cre-
GFP;Rosa26LacZ reporter system to mark myoepithelial cells and their descendants. Similar 
to αSMA+ cells, Myh11+ cells and their progeny did not contribute to the luminal cell layer of 
mammary ducts and alveoli in these mice (Fig. 4e). Basal GFP+ and total basal cells were 
sorted for progenitor and MRU assays (Fig. 4f). The vast majority (90%) of colonies derived 
from flow-sorted basal cells expressed lacZ, whereas all colonies derived from flow-sorted 
luminal cells were lacZ-negative (Fig. 4g). There was no difference in the mammosphere 
forming efficiency of basal GFP+ and total basal cells (Fig. 4h, i). Furthermore, no statistically 
significant difference was observed between the MRU frequencies in basal GFP+ and total 
basal populations (Fig. 4j). Transplanted basal GFP+ cells gave rise to ductal and alveolar 
luminal cells during mammary repopulation (Fig. 4k). The self-renewal capacity of these 
Myh11+ MRUs was demonstrated by transplanting fragments of the primary outgrowths into 
secondary recipients, since the majority (8 out of 13) of fragments formed secondary 
engraftments (Supplementary Fig. 5f). These results demonstrate that αSMA+ and Myh11+ 
myoepithelial cells have MRU and self-renewal potential.  
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To determine whether myoepithelial cells proliferate and contribute to growth of mammary 
epithelium in intact glands in vivo, we performed genetic lineage tracing analysis. Mice 
expressing Cre-recombinase fused to the oestrogen-ligand binding domain ERT2 under 
control of the αSMA-promoter (i.e. strain Acta2-Cre-ERT2) were crossed with a Rosa26LacZ 
reporter mouse. Administration of Tamoxifen to prepubertal 4-week-old females induced 
expression of LacZ in 15-20% of myoepithelial cells. One week after Tamoxifen injection, we 
detected mostly single LacZ-positive cells, small clones containing 2-4 cells and only few 
clones containing more than 4 cells (Fig. 5a-c). Remarkably, six weeks after injection, the 
amount of the clones containing more than 4 cells expanded to 15%, and numerous large 
clones consisting of 10 and more cells were detected. Furthermore, in glands from 8 day-old 
pregnant mice, multicellular clones of LacZ-positive cells were found in small lateral 
branches and alveolar buds (Fig. 5d). Consistent with other publications10,24, myoepithelial 
cells and their progeny did not contribute to the luminal cell layer of mammary epithelium.  
 
To further investigate the capacity for clonal expansion and contribution of myoepithelial 
cells to secretory alveoli during pregnancy, five sexually mature, eight-week-old, Acta2-Cre-
ERT2;Rosa26LacZ mice were treated with Tamoxifen. In two weeks, three mice were mated, 
and 5-6 weeks after Tamoxifen injection, mammary glands were dissected for analyses at 
days 12, 15 and 17 of pregnancy (Fig. 5e). X-gal staining of the glands in whole-mount, 
revealed numerous LacZ-positive cells (Fig. 5f), whereas histological examination confirmed 
the presence of LacZ-positive cells in the basal layer of the ducts and alveoli. The glands 
from pregnant animals contained larger clones of LacZ-positive cells than those from virgin 
mice following the same chase period (Fig. 5f and g), since the frequency of clones 
containing more than 4 cells was approaching 20% in the pregnant animals, and only 7-8% 
in the virgin mice (Fig. 5g).  
To determine whether myoepithelial cells contributed to the luminal cell layer, sorted basal 
and luminal cells from Acta2-Cre-ERT2;Rosa26LacZ mice were x-gal stained in suspension 
and LacZ-positive and negative cells were counted on cytospots (Supplementary Fig. 6a). 
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Basal cell populations from virgin and pregnant mice analysed 5-6 weeks after Tamoxifen 
injection (experimental schedule shown in Fig. 5e) contained from 8 to 15% of LacZ-positive 
cells, whereas the amount of labelled cells in the luminal population was very low, between 
0.17 and 0.65% (Fig. 6a). These observations were confirmed by flow cytometry analysis of 
Acta2-Cre-ERT2;R26mTmG mice obtained by mating Acta2-Cre-ERT2 and double-fluorescent 
reporter mice R26mTmG.  In this model, upon Cre-induced recombination, expression of the 
red fluorescent protein Tomato is replaced by that of GFP25. When two 13-week-old virgin, 
one 13-day-pregnant and one 1-day lactating Acta2-Cre-ERT2;R26mTmG mice were analysed 
five weeks after Tamoxifen injection, fewer than 0.1% of the GFP+ cells resided in the 
luminal compartment, whereas, the amount of GFP+ basal cells was between 31.5% and 
49.5% (Figure 6b-d and Supplementary Figure 6b). Altogether, these results strongly 
indicate that during pregnancy, basal myoepithelial cells expand within the basal 
compartment of the mammary epithelium only and do not contribute to the luminal layer. 
Finally, to trace the myoepithelial cells, labelled at puberty through long time periods 
including mammary gland remodelling during post-lactational involution, we analysed 
mammary glands of five Acta2-Cre-ERT2;Rosa26LacZ mice following two complete 
pregnancy cycles, 20-26 weeks after Tamoxifen injection (Fig. 6a, e-h and Supplementary 
Figure 6c). Mice were analysed on days 16 and 25 of 2nd involution and days 6-7 and 15 of 
3rd pregnancy. Numerous LacZ-positive cells were found in all analysed glands showing that 
labelled myoepithelial cells were long lived (Fig. 6a, f, h and and Supplementary Figure 6c). 
In 3rd pregnancy, 23-26 weeks after Tamoxifen injection, the amount of LacZ-positive cells in 
the basal compartment was approximately 10%, i.e., close to that observed in the 1st 
pregnancy, after 5-6 weeks of chase (Fig. 6a). Sorted luminal population contained 0.17-
0.2% of labelled cells only (Fig. 6a). Histological observations were in line with these data, 
no labelled luminal cells were revealed (Fig. 6h, right panel). 
Altogether, these data show that myoepithelial cell-derived clones can expand in the basal 
cell layer of both mammary ducts and growing alveolar structures during normal mammary 
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gland homeostasis, survive through involution and contribute to the basal layer of ducts and 
alveoli in multiple pregnancies.  
 
DISCUSSION 
The basal cell population is perceived to be a mixed population consisting of rare, 
undifferentiated mammary stem cells interspersed with a population of relatively 
differentiated myoepithelial cells5-7,26. However, MRUs have proven to be exceptionally 
difficult to prospectively isolate from the myoepithelial cells that make up the bulk of the 
basal cell compartment by using flow cytometry, nor have dramatic differences in the gene 
signatures of MRU-enriched and myoepithelial-enriched cell fractions been observed5. This 
suggests that there is a close developmental relationship between MRUs and myoepithelial 
cells, and the differences between these cells may be subtle. Supporting this concept is the 
observation that MRU numbers can fluctuate up to 14-fold within the 2 to 3 days between the 
oestrus and dioestrus phases of the mouse oestrous cycle27. Such a large variation in MRU 
numbers within such a short time period suggests that pre-existing basal cells are being 
activated to become MRUs, rather than expansion of the MRU subpopulation via cell 
division. One possible mechanism behind this that myoepithelial cells could function as 
MRUs when primed for cell division; in support of this hypothesis, inducing basal cell 
proliferation in our cell culture system permitted a ~460-fold expansion of MRUs after 7 days 
in culture. Since the majority of single-cell-derived basal colonies contained a MRU, this 
demonstrates that de novo activation of MRUs occurred and that myoepithelial cells 
contributed to the MRU expansion. It is important to note, however, that culture may activate 
myoepithelial progenitors rather than differentiated myoepithelial cells, although if this were 
the case, the myoepithelial progenitor population would have to be quite large to account for 
the high proportion of basal cells that can become MRUs. A more plausible explanation is 
that culture itself may reprogram myoepithelial cells to a more primitive state. 
 
We have demonstrated that myoepithelial cells can acquire multilineage MRU potential 
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during culture. Moreover, we have observed that freshly isolated Myh11+ basal cells have 
MRU capacity and that all detectable MRUs are αSMA+, again indicating the myoepithelial 
nature of MRUs. Currently it is not known if all cells of the myoepithelial cell lineage can 
function as MRU, or just a restricted subset. Furthermore, we demonstrate using a lineage 
tracing approach that cells of the myoepithelial lineage function as lineage-restricted stem 
cells in both the virgin state and in pregnancy. One plausible explanation for the discrepancy 
in the lineage potential of basal cells between lineage tracing studies vs. transplantation 
assays is that the intercellular and/or cell-extracellular matrix interactions within the intact 
mammary basal compartment favour the myoepithelial cell fate and prevent asymmetric 
divisions required for the acquisition of luminal phenotype, whereas disruption of these 
interactions during tissue dissociation and subsequent transplantation results in loss of the 
factors that normally inhibit the multipotential cell behaviour of basal cells.  
 
Our lineage tracing data are in line with the results described by Van Keymeulen and 
colleagues, who reported that that basal compartment of the mammary epithelium harbours 
uni-potent stem cells restricted to basal myoepithelial lineage8,10. However a recent study by 
Rios et al.11 provided evidence that mammary basal cells, traced using basal keratin gene 
promoters or Lgr5, contribute to both the basal and the luminal compartments of mammary 
ducts and alveoli. Similarly, tracing of Wnt-responsive cells suggested the existence of 
bipotent mammary stem cells residing in the basal cell layer9. Lineage-tracing assays 
provide valuable data on the hierarchy of mammary epithelial cells, however this 
experimental approach can be limited by the specific characteristics of distinct promoter 
constructs. Currently, little is known regarding the heterogeneity of the mammary basal 
epithelial compartment, and how different promoters may target different cell populations 
that have distinct developmental potentials. Future experiments will be required to clearly 
define and characterise the complexity of the mammary stem and progenitor cell 
populations. 
In brief, we show that in culture, a high proportion of myoepithelial cells can give rise to   
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MRUs and that freshly sorted myoepithelial cells have MRU capacity. We also demonstrate 
that in intact virgin and pregnant mouse mammary glands, cells of the myoepithelial lineage 
function as unipotent long-lived stem cells and contribute to the basal cell layer only.  
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FIGURE LEGENDS 
Figure 1. The vast majority of mouse basal cells express alpha-smooth muscle actin 
(αSMA). High EpCAM expression enriches for mammary stem cells and proliferating 
cells.  
(a) Flow cytometry plot showing stromal (black), luminal (blue) and basal (red) cell 
populations. The basal population has been subdivided into EpCAMhigh (brightest 20%) and 
EpCAMlow (remaining 80%) subpopulations (b) Double-sorted basal EpCAMhigh and 
EpCAMlow cells stained by immunocytochemistry for αSMA and isotype control inset. Mean 
(± SEM) of 5 independent experiments. Scale bars = 50 μm. (c) Relative mRNA transcript 
abundance of Acta2, Myh11 and Oxtr in basal EpCAMhigh and EpCAMlow cells as detected by 
real-time PCR. Data normalised to Actb and Rplp0 reference genes. Mean (± SEM) of 4 
independent experiments. (d) Relative abundance of αSMA protein in basal EpCAMhigh and 
EpCAMlow cells as detected by Western blot (left). Data normalised to cytokeratin 14 (CK14) 
abundance. Mean (± SEM) of 3 independent experiments. A representative blot (right) 
showing protein standards (red), CK14 (55kDa) and αSMA (42kDa) bands (green). (e) 
Mammary repopulating unit (MRU) frequency of sorted basal EpCAMhigh and EpCAMlow cells. 
Data for Basal EpCAMhigh and Basal EpCAMlow pooled from 5 independent experiments. ** P 
= 0.0002. (f) Percentage of flow-sorted basal EpCAMhigh and EpCAMlow cells positive for 
IdU/BrdU. Data is presented as the mean (± SEM) of 9 independent experiments. * P = 0.04. 
(g) Distribution of IdU/BrdU+ cells within the basal population.  
 
Figure 2. Short-term culture increases MRU numbers by ~460-fold.  
(a) MRU frequency in freshly isolated and post-cultured basal cells with estimated number (± 
SEM) of MRUs per dish. Data pooled from 5 independent experiments for non-cultured basal 
and from 4 independent experiments for 7-day-cultured basal cells. (b) Representative 
engrafted fat pads derived from non-cultured basal cells and 7-day-cultured basal cells. 
Scale bar = 2 mm. 
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Figure 3. A high proportion of single-cell-derived basal colonies contain a MRU.  
(a) Table showing single-cell cloning efficiency of basal EpCAMhigh and EpCAMlow cells and 
the proportion of single-cell-derived basal colonies that engrafted when transplanted into 
cleared mammary fat pads of NSG pups. Cloning efficiencies are presented as the mean± 
SEM, with data pooled from 4 independent experiments. (b) Representative images of a 
GFP+ basal colony and a GFP+ engraftment from a transplanted basal colony (which was 
derived from a single basal EpCAMhigh cell); scale bars = 500 µm. Images of sections 
through an engrafted fat pad stained for various markers by immunohistochemistry; scale 
bars = 100 µm.  
 
Figure 4. Myoepithelial cells have MRU activity. 
(a) Sections of mammary glands from Acta2-GFP mice (C57BL/6J) stained for αSMA and 
GFP by immunohistochemistry. Representative image seen in 3 independent samples. 
Scale bar = 100 µm. (b) Flow cytometry dot plot showing GFP+ (αSMA+) events back-gated 
onto the EpCAM and CD49f plot. (c) CFE of basal αSMA+ and basal αSMA- cells. Mean 
(±SEM) of 4 independent experiments. ** P = 0.0003. (d) MRU frequency in basal αSMA+ 
and basal αSMA- cells. Data pooled from 3 independent experiments. ** P = 0.0002. (e) 
Wholemount (left) and sections (center and right) of X-gal-stained mammary glands from 
Myh11-Cre-GFP;Rosa26LacZ virgin (left and center) and 15-day-pregnant (right) mice. 
Images were observed in 8 (left panel) and 4 (central and right panels) independent 
samples. Scale bar for left panel = 1.8 mm. Scale bar for central panel = 120 µm. Scale bar 
for right panel = 50 µm. (f) Flow cytometry dot plot showing resolution of total basal and 
basal Myh11+ cells. Five independent samples analysed. (g) X-gal-stained colonies derived 
from flow-sorted basal and luminal cells. Scale bar = 5 mm. (h) Mammospheres derived 
from basal Myh11+ and total basal cells. Scale bar = 290 µm. (i) Mammosphere forming 
efficiency of basal Myh11+ and total basal cells. Data showing the mean sphere-forming 
efficiency from one of two independent experiments is presented. Data is derived from 3 
technical replicates. (j) MRU frequency in basal Myh11+ and total basal cells. Data pooled 
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from 3 independent experiments. (k) Wholemount and section of a primary engraftment 
(above) developed from basal Myh11+ cells in virgin (left and central) and 12-day-pregnant 
(right) hosts and a secondary engraftment (below) in a virgin host. Nineteen primary and 
three secondary outgrowths were x-gal stained in whole mount, of which three primary and 
three secondary outgrowths were sectioned. Scale bars for wholemounts = 1.8 mm. Scale 
bars for sections = 50 µm.  
  
Figure 5. Myoepithelial cell derived clones can undergo expansion within the basal 
layer of intact mammary glands and survive after multiple pregnancies.  
Experimental schedule for (b) and (c). (b) Sections of whole-mount x-gal stained mammary 
glands from Acta2-Cre-ERT2;Rosa26LacZ mice injected with Tamoxifen at 4 weeks and 
dissected 1 and 6 weeks later, as indicated. Scale bar = 52 μm (c) Graph showing the 
percentage of myoepithelial cell clones containing 1, 2-4 and > 4 LacZ-positive cells in the 
glands dissected 1 week (2 mice) and 6 weeks (3 mice) after Tamoxifen injection. The 
values shown are means+SEM from 4 mammary fat pads at each time point. *P < 0.01. For 
details see On Line Methods. (d) Section of whole-mount x-gal stained mammary gland from 
Acta2-Cre-ERT2;Rosa26LacZ mouse injected with Tamoxifen at 4 weeks and dissected 5 
weeks later, on day 8 of pregnancy. The arrows point to LacZ-positive cells in the basal layer 
of small lateral branches and emerging alveolar buds. Scale bar = 90 μm. (e) Experimental 
schedule for (f) and (g). (f) Fragments (upper panels) and sections (lower panels) of whole-
mount x-gal stained mammary glands from 13-week-old virgin, 12- (P12) and 17-day-
pregnant (P17) Acta2-Cre-ERT2;Rosa26LacZ mice dissected 5 and 6 weeks after Tamoxifen 
injection, as indicated. Arrows point to LacZ-positive alveoli. D, mammary duct, BV, blood 
vessel. Scale bar = 0.35 mm for upper panels and 65 μm for lower panels. (g) Graph 
showing the percentage of myoepithelial cell clones containing 1, 2-4 and > 4 LacZ-positive 
cells in the ducts from virgin and pregnant Acta2-Cre-ERT2;Rosa26LacZ mice. V1 and V2, 
two 13-week-old virgin mice; P12, P15 and P17, 1st pregnancy days 12, 15 and 17, 
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respectively. The values represent means+SEM of 3 counts performed in different gland 
areas (for details see On Line Methods).  
 
Figure 6. The progeny of myoepithelial cells is restricted to the basal cell layer and 
survives after multiple pregnancies. 
(a) A graph showing the percentage of LacZ-positive cells in basal and luminal cell 
populations isolated from Acta2-Cre-ERT2;Rosa26LacZ mouse and x-gal stained in 
suspension. V, 13-week-old virgin, P15 and P17, 1st pregnancy days 15 and 17, 
respectively; 3rdP6 and 3rdP15, 3rd pregnancy, days 6-7 and 15, respectively. Experimental 
schedule for V, P15 and P17 is shown in Figure 5e, for 3rdP6 and 3rdP15, in (g). Data shown 
for P15, P17 and 3rdP15 were obtained with inguinal mammary glands from one mouse, in 
each case, for V and 3rdP6, with pooled inguinal glands from two 13-week-old virgin and two 
6-7-day-pregnant mice, respectively. (b) A mammary gland fragment from virgin Acta2-Cre-
ERT2;R26mTmG mouse analyzed five weeks after Tamoxifen injection. Scale bar = 0.35 mm. 
(c) and (d) Flow cytometry dot plots showing GFP expression in luminal and basal cell 
populations isolated from virgin (c) and 1-day-lactating (d) Acta2-Cre-ERT2;R26mTmG mice. 
Experimental schedule for (b-d) was same as shown in Figure 5e. Red ovals indicate luminal 
(L) and basal (B) cell populations. (e) and (g) Experimental schedules for (f) and (h), 
respectively. (f) Fragment of whole-mount x-gal stained mammary gland from Acta2-Cre-
ERT2;Rosa26LacZ mice injected with Tamoxifen at 4 weeks and analysed 25 weeks later, on 
day 16 of the involution following 2nd pregnancy (2nd Inv16). Scale bar = 0.87 mm. In (e) and 
(g), 1st and 2nd P,L,Inv, first and second pregnancy, lactation and involution cycles, 
respectively. (h) A fragment (left) and a section (right) of x-gal stained mammary glands from 
Acta2-Cre-ERT2;Rosa26LacZ mice injected with Tamoxifen at 4 weeks and analysed 23 
weeks later, on day 15 of third pregnancy (3rdP15). Scale bar = 0.87 mm, left panel and 50 
mm, right panel. Arrows in (f) and (h) point to alveoli. BV, blood vessel; D, mammary duct.  
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METHODS 
Mice  
The C57BL/6J.CBA-Tg(Actb-EGFP) and NOD/SCID IL2Rγc-/- mice were a kind gift 
from Fiona Watt. The Acta2-GFP mice were a kind gift from Sussan Nourshargh and 
Michaela Finsterbusch and were made by Jen-Yue Tsai and Sanai Sato28.  
Establishment of Acta2-Cre-ERT2 mouse strain has been previously described29. 
Myh11-Cre-EGFP mice were purchased from Jackson Laboratories; Rosa26LacZ 
reporter strain, carrying a loxP-stop-loxP-LacZ cassette, was kindly provided by 
Philippe. Soriano30. R26mTmG double-fluorescent reporter mouse strain25 obtained 
from Jackson ImmunoResearch Laboratories Inc. was kindly provided by Sylvia Fre. 
All experiments and procedures involving animals were in strict accordance with the 
French and European legislations for the Protection of Vertebrate Animals used for 
Experimental and other Scientific Purposes and were approved by the Departmental 
Direction of Populations Protection (approval number: B75-05-18). Husbandry and 
supply of animals as well as maintenance and care of the animals in exempt of 
pathogen species environments before and during experiments fully satisfies the 
animal’s needs and welfare. No statistical method was used to predetermine sample 
size, and experiments were not randomized. The investigators were not blinded to 
allocation during experiments and outcome assessment.  
 
Mammary gland dissociation into single cell suspension 
The number 3 and 4 mammary glands were dissected from 10-15-week-old virgin, 
female C57BL/6J mice were dissociated for 14-16 h at 37°C in 1:1 DMEM/F12 (+ 
2.5mM L-glutamine + 15mM HEPES; Gibco) + 1 mg/ml collagenase (Roche) + 100 
U/ml hyaluronidase (Sigma) + 50 µg/ml gentamicin (Gibco). The mammary glands 
were then processed to single cells as previously described6. Mammary glands from 
Myh11-Cre-GFP, Myh11-Cre-GFP;Rosa26LacZ, Acta2-Cre-ERT2;Rosa26LacZ and 
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Acta2-Cre-ERT2;R26mTmG mice were dissociated and processed for single cell 
suspension and flow cytometry as described elsewhere8-10. 
 
Flow cytometry and immunofluorescence 
Mammary cells were incubated with 10% normal rat serum for 10 min on ice to pre-
block before antibody staining. All antibody incubations were for 10 min on ice in HF 
media: Hank’s Balanced Salt Solution (Gibco) + 10 mM HEPES (Sigma) + 2% fetal 
bovine serum (FBS; Gibco). Mouse mammary cells were stained with the following 
primary antibodies: 1 µg/ml CD31-biotin (clone 390, eBioscience); 1 µg/ml CD45-
biotin (clone 30-F11, eBioscience); 1 µg/ml Ter119-biotin (clone Ter119, 
eBioscience); 1 µg/ml BP-1-biotin (clone 6C3, eBioscience); 1 µg/ml EpCAM-Alexa 
Fluor 647 (clone G8.8, Biolegend) and 2 µg/ml CD49f-Alexa Fluor 488 (clone GoH3, 
Biolegend). In experiments using cells from C57BL/6J.CBA-Tg(Actb-EGFP) and 
Acta2-GFP mice, 2 µg/ml CD49f-Pacific Blue (clone GoH3, Biolegend) antibody was 
used instead of CD49f-Alexa Fluor 488. Mouse cells were then stained with 0.4 µg/ml 
streptavidin-APC-Cy7 (Biolegend). 1 µg/ml DAPI (Invitrogen) was used to detect 
dead cells. Cells were filtered through a 30 µm cell strainer prior to sorting. For 
experiments using cells from Myh11-Cre- EGFP mice, the following conjugated 
antibodies were used: anti-CD24-PE-Cy5 (clone M1/69; BD Biosciences), anti-
CD49f-PE (clone GoH3; BD Biosciences), anti-CD45-APC (clone 30-F11; 
Biolegend), anti-CD31-APC (clone MEC13.3; Biolegend). For separation of basal 
and luminal cells from Acta2-Cre-ERT2;Rosa26LacZ mice, anti-CD49f antibody was 
FITC-conjugated. For analysis of Acta2-Cre-ERT2;R26mTmG mice, anti-CD24-PE 
(clone M1/69; BD Biosciences) and anti-CD49f-PECy7 (clone GoH3; Biolegend) 
were used. Sorting of cells was done using a FACSAria I (BD Biosciences) except for 
Figure 4f and Figures 6c-d, where a FACSVantage (BD Biosciences) was used. 
Single-stained control cells were used to perform compensation manually. Matched 
isotype control antibodies conjugated to each fluorochrome were used to control for 
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background staining and fluorescence-minus-one controls were used to set gates. 
Flow cytometry data were analysed using FlowJo software (Tree Star, Inc.). 
 
Instrument configuration: 
FACSAria I lasers: 
Lasers Wavelength Power 
UV   375 nm 20 mW 
Violet   405 nm 50 mW 
Blue   488 nm 80 mW 
Red   633 nm 25 mW 
561   561 nm 100 mW 
 
FACSAria I detectors: 
Name Dichroic 
filter 
Band pass 
filter 
Wavelength 
range 
Dyes 
UV-C None 424/44 402-446 DAPI, Hoechst 33342 
Violet-C None 450/50 425-475 Pacific Blue 
Blue-D 600LP 610/20 600-620 PI (Propidium Iodide) 
Blue-E 550LP 575/25 562-588 PE 
Blue-F 505LP 530/30 515-545 Alexa Fluor 488 
Red-A 755LP 780/60 750-810 APC Cy7 
Red-C None 660/20 650-670 Alexa Fluor 647 
 
LSRII lasers: 
Lasers Wavelength Power 
UV 355 nm 20 mW 
Violet 405 nm 25 mW 
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Blue 488 nm 20 mW 
Red 633 nm 25 mW 
 
LSRII detectors: 
Name Dichroic filter Band pass filter Wavelength range Dyes 
UV-B None 450/50 425-475 DAPI 
Blue-F 505LP 530/30 515-545 FITC 
 
Quality check: 
The laser alignment was checked regularly using BD™ Cytometer Setup & Tracking 
Beads and 8-peak rainbow beads (BD Biosciences). The PMT settings were set such 
that the unstained cells were placed in the first decade of fluorescence. 
 
Compensation: 
Single stained control cells were used for each dye used. Compensation was 
performed manually. A representative compensation matrix of the FACSAria I is 
shown below: 
 FSC 
PMT 
UV C Red C Red A Blue F Blue A Blue E Blue B 
FSC 
PMT 
100% 0% 0% 0% 0% 0% 0% 0% 
UV C 0% 100% 0% 0% 0% 0% 0% 0% 
Red  C 0% 0% 100% 24% 0% 0% 0% 1.1% 
Red A 0% 0% 3% 100% 0% 1% 0% 0% 
Blue F 0% 0% 0% 0% 100% 0% 45% 0% 
Blue A 0% 0% 0% 11.5% 0% 100% 5.4% 0.9% 
Blue E 0% 0% 0% 0% 1% 0.7% 100% 4.5% 
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Blue B 0% 0% 8% 0% 0% 15% 0% 100% 
 
Gating strategy: 
The following isotype controls were used to check for background staining: Rat 
IgG2a, κ-Alexa Fluor 488 (clone RTK2758, Biolegend); Rat IgG2a,k-Alexa Fluor 647 
(clone RTK2758, Biolegend); Armenian Hamster IgG-PE (clone HTK888; Biolegend); 
Rat IgG2b, κ-PerCP (clone RTK2758, Biolegend). Representative sort plots with 
typical gates are shown below for the sorting of basal cells. Doublets, dead cells and 
contaminating haematopoietic, endothelial and stromal cells are gated out. High 
expression of EpCAM (EpCAMhigh) is defined as the brightest 20% of the basal 
population. 
 
Proliferation and apoptosis assays 
To assess proliferation status in non-cultured cells, freshly dissociated mammary 
cells were incubated with 10 µg/ml Hoechst 33342 (Sigma) for 45 min at 37°C. Cells 
were then stained with antibodies as stated above except that 0.5 µg/ml propidium 
iodide (PI; Sigma) was used instead of DAPI to detect dead cells. The full gating 
strategy is shown below. Hoechst2n and Hoechst4n cells were visualised on an 
ImageStream imaging flow cytometer (Amnis). For synthetic nucleoside injections, 
mice were injected with a 150 mg/kg dose of BrdU or IdU (Sigma), were culled 1-7 h 
post-injection, their mammary glands removed and dissociated and basal cells 
isolated and fixed on slides in cold methanol for 5 min at -20°C. The cells were 
incubated with 2N HCl for 30 min at 25°C to denature the DNA. A primary antibody 
that recognises both BrdU and IdU (clone B44; BD Biosciences) was used at a 1 
µg/ml and incubated overnight at 4°C followed by an anti-rabbit IgG-Alexa Fluor 555 
secondary antibody (Invitrogen) at 1 µg/ml for 1 h at 25°C. Approximately 500 basal 
EpCAMhigh and EpCAMlow cells for each independent sample were scored by eye on 
a Nikon upright confocal microscope at 60x magnification. To assess proliferation 
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status post-culture, cells were trypsinised and incubated with 10 µg/ml Hoechst for 
45 min at 37°C and were then stained with EpCAM-Alexa Fluor 647 and PI. FlowJo 
was used for all cell cycle analysis.  
 
Immunocytochemistry and immunofluorescence: 
Purified basal cells were allowed to adhere to poly-L-lysine coated slides at 37°C for 
15 min. Basal cells and colonies were fixed in 1:1 acetone/methanol and 
permeabilised with 0.025% Triton X-100 in TBS for 10 min before pre-blocking with 
10% normal goat or donkey serum (Sigma) in TBS for 1 h at 25°C. For 
immunohistochemistry, paraffin-embedded tissue sections were de-waxed in xylene, 
gradually rehydrated and then boiled in citrate buffer pH6 for 10 min before pre-
blocking with 10% normal donkey serum in TBS for 1 h at 25°C or with 1%BSA/0.1% 
Tween 20/PBS. Rabbit anti-mouse polyclonal antibodies against αSMA (cross reacts 
with human; Abcam), smooth muscle myosin heavy chain (Abcam), cytokeratin 5 
(Abcam), cytokeratin 14 (cross reacts with human; Covance), cytokeratin 18-biotin 
(cross reacts with human; Abcam), mucin 1 (Abcam) and β-casein (gift from Christine 
Watson) were used at 2 µg/ml incubated overnight at 4°C. A chicken anti-mouse 
polyclonal antibody against GFP (Abcam) was used at 0.25 µg/ml. Cells and sections 
were then stained with a biotinylated donkey anti-rabbit IgG antibody or biotinylated 
donkey anti-chicken IgG antibody (Jackson ImmunoResearch) at 1 µg/ml for 1 h at 
25°C. The Vectastain Elite ABC kit (Vector Labs) was used for avidin-horseradish 
peroxidase conjugation and 3,3'-diaminobenzidine (DAB) containing hydrogen 
peroxide (Vector Labs) was added and incubated for 2-10 min. For 
immunofluorescence, a goat anti-rabbit IgG-Alexa Fluor 555 (Invitrogen) was used at 
1 µg/ml incubated for 1 h at 25°C. DAPI was used at 1 µg/ml to visualise cell nuclei.  
 
Cell culture 
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Culture dishes were coated with Growth Factor Reduced (GFR) Matrigel (BD 
Biosciences) diluted 1:60 in PBS and incubated for 1 h at 37°C. Basal cells were 
cultured in FAD media: 3:1 DMEM/F12 (+1.8x10-4M adenine + 1.8x10-3M calcium) + 
10% FBS (PAA) + 0.5 μg/ml hydrocortisone (Sigma) + 10-10M cholera toxin (Enzo 
Life Sciences) + 10 ng/ml epidermal growth factor (EGF, Peprotech) + 5 μg/ml insulin 
+ 50 μg/ml gentamicin. Cell culture media was supplemented with 10 μM Y-27632 
(Sigma) unless stated otherwise. Irradiated NIH 3T3 fibroblasts were seeded at 104 
cells/cm2. Cultures were kept at 37°C in a 5% (vol/vol) CO2, 5% (vol/vol) O2 
atmosphere for 7 days. For colony formation assays, mammary cells were seeded at 
10-50 cells/cm2 and cultured for 7 days (10 days for human cells) before fixation in 
1:1 acetone/methanol. Colonies were stained with Wright-Giemsa (Fisher) and 
counted under a microscope at low magnification. For transplantations and analysis, 
cultured cells were trypsinised and sorted by flow cytometry using DAPI and EpCAM 
to isolate live epithelial cells and exclude dead cells and fibroblast cells. For some 
experiments, recombinant Human TGFβ1 (R&D Systems), SB 431542 hydrate 
(Sigma), blebbistatin (Sigma), latrunculin B (Enzo), cytochalasin D (Tocris 
Bioscience), jasplakinolide (Enzo) and H-1152 dihydrochloride (Tocris Bioscience) 
were added to cell culture media for some experiments. In Fig. 4g, freshly sorted 
cells were cultured in DMEM/F12 medium containing B27 (Gibco) + 1% FBS. For X-
gal staining, colonies were fixed in 2% formaldehyde, 0.2% glutaraldehyde, 0.02% 
NP-40 in PBS at 4°C for 4 min, washed with PBS, incubated with the X-gal staining 
solution (0.025% X-gal, 3 mM K3Fe(CN)6, 3 mM K4Fe(CN)6, 1.5 mM MgCl2, 15mM 
NaCl, 40mM HEPES) overnight at 30°C, post-fixed with 4% formaldehyde, and 
counterstained with nuclear Fast Red. Colony-formation assay with basal and luminal 
cells from Myh11Cre-GFP; Rosa26 mice was performed three times with three 
technical replicates in each case. For mammosphere assays, freshly isolated cells 
were seeded at a density of 5,000 cells/well on ultralow-adherent 24-well plates 
(Corning) in DMEM/F12 containing B27 (Gibco), 20 ng/mL EGF (Invitrogen), 20 
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ng/mL bFGF (Gibco), 4 µg/mL heparin (Sigma), 10 µg/mL insulin (Sigma) 
supplemented with 2% GFR Matrigel. The mammospheres were dissociated every 
two weeks with 0.05% trypsin (Gibco) and were re-seeded at 5,000 cells/well.  
 
Analysis of myoepithelial cell clonal expansion in situ and quantitative 
evaluation of LacZ-labeling in basal and luminal compartments  
For analyses of clonal expansion and progeny tracing at puberty, 4-week-old Acta2-
Cre-ERT2;Rosa26 females were i.p. injected twice with 1 mg of Tamoxifen within 24 
hours. Mice were sacrificed one week (2 mice) and six weeks (three mice) after 
injection, glands dissected and processed for whole-mount x-gal staining as 
described elsewhere (Biology of the Mammary Gland, http://mammary.nih.gov). 
Between 339 and 511 clones were counted for 1-week chase time point, and 
between 260 and 528 for 6-week chase. 
For analyses of clonal expansion and progeny tracing during pregnancy, 8-week-old 
Acta2-Cre-ERT2;Rosa26LacZ and Acta2-Cre-ERT2;R26mTmG  virgin females were i.p. 
injected twice with 0.75 mg of Tamoxifen within 24 hours, mated two weeks later and 
analysed 5-6 weeks after Tamoxifen injection at different pregnancy stages (Fig. 5e). 
For tracing the progeny of myoepithelial cells after two pregnancies, 4-week-old 
females were injected twice with 0.75 mg of Tamoxifen within 24 hours, mated at 8 
weeks, allowed to lactate for one week, mated again after three weeks of involution 
and analysed after second lactation, either during involution (chase of 20 weeks), or 
at third pregnancy (chase of 22-26 week)   
For histological analyses, x-gal-stained glands were embedded in paraffin, 7 µm-
thick sections were cut, de-waxed and stained with nuclear Fast Red. For analyses 
of clonal expansion at pregnancy, clones were counted in 3 different gland areas 
and, at least, 9 sections per gland were analysed. 335, 281, 680, 648 and 492 clones 
were counted for V1, V2, P12, P15 and P17 samples, respectively. 
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To evaluate the amount of LacZ-positive cells in basal and luminal epithelial 
compartments, single cell suspensions were obtained from inguinal mammary glands 
of Acta2-Cre-ERT2;Rosa26LacZ mice as described above, basal and luminal cells 
isolated by flow cytometry, x-gal  stained in suspension and LacZ-positive and 
negative cells were counted on cytospots. In each case, at least, 500 basal and 
2,000 luminal cells were counted.    
 
Cell injections into cleared fat pads 
All animal work conducted in the UK was approved by the Cambridge Institute Local 
Ethics Committee and the Home Office and all animal work conducted in France was 
conducted in accordance with French veterinary guidelines and those formulated by 
the Council of Europe for experimental animal use (L358-86/609EEC). Cells were 
suspended in 65% HF media + 25% GFR Matrigel + 10% trypan blue solution (0.4%, 
Sigma), except for in Fig. 4j where 50% GFR Matrigel was used, at a concentration 
such that a 10 µl injection volume contained the desired cell dose. The endogenous 
mammary epithelium in the inguinal (number 4) glands of 3-week-old female 
C57BL/6J or NOD/SCID IL2Rγc-/- pups was cleared and cells were injected into 
cleared fat pads as previously described 31. The mice were mated 3 weeks after 
surgery and the number 4 glands were removed during pregnancy. Glands were 
fixed overnight in Carnoy’s fixative. GFP+ glands were visualised under a 
fluorescence microscope at low magnification and were then fixed in 4% 
paraformaldehyde for 1 h at 25°C before paraffin embedding. For whole-mount 
analysis, glands were stained overnight in carmine alum (Sigma) and analysed under 
a microscope at low magnification. After X-gal staining in whole-mount, glands were 
dehydrated and post-fixed in acetone for 30 min before carmine staining. For 
secondary transplantations, primary outgrowths (that contained GFP+ epithelium) 
were dissociated, made into a single cell suspension and were transplanted back into 
cleared mammary fat pads as described above except for in Supplementary Fig. 3f 
 10
where 1 mm3 fragments, containing epithelial ducts that were clearly visible under a 
dissecting microscope, were re-transplanted into cleared mammary fat pads.  
 
RNA extraction: 
Total RNA was extracted from non-cultured, 1-day-cultured and 7-day-cultured basal 
cells using the RNeasy Plus Mini kit (Qiagen). The RNA was quantified using a 
NanoDrop 1000 spectrophotometer (Thermo Scientific) and quality checked using a 
2100 Bioanalyser (Agilent). All samples had a RNA integrity number ≥ 8.  
 
Microarray summary: 
Total RNA was prepared for microarray analysis using an Illumina TotalPrep RNA 
Amplification kit (Ambion). The cRNA was hybridised to a MouseWG-6 v2.0 
Expression BeadChip (Illumina). All microarray data analyses were carried out on R 
using Bioconductor packages32. Raw intensity data from the array scanner were 
processed using the BASH33 and HULK algorithms as implemented in the beadarray 
package34. Log2 transformation and quantile normalisation of the data from 4 
independent experiments was performed. Differential expression analysis was 
carried out using the limma package35. Differentially expressed genes were selected 
using a p-value cut-off of <0.01 after global application of a false discovery rate 
correction for multiple contrast testing. The microarray data can be accessed via the 
Gene Expression Omnibus (GEO, series accession number GSE31347). Full 
microarray methods in accordance with the MIAME guidelines can be found at the 
GEO website.  
 
Real-time PCR 
Total RNA was extracted, quantified and quality checked as described above. 
Reverse transcription of the total RNA was performed using the SuperScript VILO 
cDNA Synthesis Kit (Invitrogen). Assuming a 1:1 conversion of RNA to cDNA, 2ng of 
 11
cDNA was used per reaction. TaqMan Fast Universal PCR Master Mix (Applied 
Biosystems) and TaqMan Gene Expression assays (Applied Biosystems) were used 
following the manufacturer’s protocol. Reactions were done in 12.5µl volumes in 
triplicate using a 7900HT Fast Real-Time PCR System (Applied Biosystems) under 
the following conditions: 95°C for 20 sec followed by 40 cycles of 95°C for 1 sec and 
60°C for 20 sec. Relative transcript levels were calculated using the comparative CT 
method and were normalised to the reference genes Actb and Rplp0. Full real-time 
PCR methods in accordance with the MIQE guidelines are detailed as follows:  
 
MIQE checklist: 
Experimental design: Experimental groups: Basal pre-culture, 1-day-cultured basal 
cells, 7-day-cultured basal cells. Control groups: No Template Control (NTC; no 
cDNA), RT- (no SuperScript). Technical replicates were done in triplicate. Relative 
transcript abundance was averaged from 3 independent biological replicates. Real-
time PCR assays were performed by the lead author.  
Sample: Mammary glands from 10-14 week old, female, virgin C57BL/6J mice were 
macrodissected and dissociated for 14-16 h at 37°C in DMEM/F12 containing 
collagenase and hyaluronidase. Mammary glands were treated with ammonium 
chloride, trypsin, dispase and DNase and then filtered to obtain a single cell 
suspension. Mammary cells were stained with fluorochrome-conjugated antibodies 
and the viability dye DAPI and were then passed through a cell sorter. Cultured basal 
cells were grown on Matrigel-coated cell culture plastic in FAD media supplemented 
with 10µM Y-27632 for 1-7 days at 37°C in a 5% (vol/vol) CO2, 5% (vol/vol) O2 
atmosphere. 
Nucleic acid extraction: Total RNA was extracted using the RNeasy Plus Mini kit 
(Qiagen) following the manufacturer’s instructions. The RNA was quantified using a 
NanoDrop 1000 spectrophotometer (Thermo Scientific) and quality checked using a 
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2100 Bioanalyser (Agilent). Most samples had an RNA integrity number (RIN) ≥8 
(Supplementary Table 2). 
 
Reverse transcription: The SuperScript® VILO™ cDNA Synthesis Kit (Invitrogen; 
catalogue number 11754) was used following the manufacturer’s protocol and 
reaction conditions. Reaction volumes were 20µl with 150ng of total RNA. 
Temperature and time: 25°C for 10 min, 42°C for 120 min, 85°C for 5 min. The vast 
majority of Cqs were undetermined for no-reverse transcription controls but where 
amplification did occur, Cq values were ≥37. Cq values with reverse transcription were 
between 20-35 depending on transcript abundance. All cDNA was stored at -20°C.  
The qPCR target information is reported in Supplementary Table 3.   
 
qPCR protocol 
TaqMan® Gene Expression Assays (Applied Biosystems) were used following the 
manufacturer’s protocol. Final concentrations were 900nM for primers and 250nM for 
the TaqMan® MGB probe (6-FAM dye-labeled). Reaction conditions: TaqMan® 
Gene Expression Assay (20x) + TaqMan® Fast Universal PCR Master Mix (2x; 
contains DNA polymerase) No AmpErase® UNG (Applied Biosystems) + 2ng cDNA 
(0ng for NTC) + H2O. Reactions were done in triplicate in 12.5µl volumes containing 
2ng of RNA converted to cDNA. A 7900HT Fast Real-Time PCR System (Applied 
Biosystems) was used with the following thermocycling parameters: 95°C for 20 sec 
followed by 40 cycles of 95°C for 1 sec and 60°C for 20 sec.  
 
qPCR validation: 
Amplification efficiencies:  
Gene 
Symbol 
 
Slope 
 
y intercept 
PCR 
efficiency
 
r2 
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Acta2 -3.56 26.2 0.91 1 
Actb -3.65 23.1 0.88 1 
Myh11 -3.63 23.7 0.89 1 
Rplp0 -3.60 20.3 0.90 1 
 
The linear dynamic range was from 0.02-2ng of cDNA per reaction. At 0.002ng of 
cDNA, Cq values for less abundant targets became variable (Cqs>35 and triplicates 
differed by >1 Cq).  
 
Data analysis: 
qPCR data were analysed and Cq values determined using the 7900HT Sequence 
Detection System software (Applied Biosystems). No template controls did not 
amplify and the Myh11 no reverse transcription (RT-) control did not amplify. The 
exceptions were amplification for Acta2, Actb and Rplp0 RT- controls with Cq values 
≥37 which were 10-15 Cqs greater than those for samples with reverse transcribed 
template. Actb and Rplp0 were used as reference genes based on their use in the 
literature and because their expression did not differ significantly between the 
samples according to the microarray data. The geometric mean of the 2 reference 
gene Ct values was used for normalisation.  
 
Western blotting: 
An equal number of flow-sorted basal EpCAMhigh and EpCAMlow cells were 
centrifuged at 470 x g, the supernatant removed and cells lysed in 10µl of CHAPS 
lysis buffer (20 mM Tris, 8M Urea, 5 mM Magnesium Acetate, 4% CHAPS; pH to 8.0; 
Amersham). Protein lysates were sonicated for 30 sec and diluted with NuPAGE 
LDS sample buffer and NuPAGE reducing agent (Invitrogen) before being run on a 
NuPAGE Bis-Tris gel (Invitrogen) in NuPAGE MOPS SDS running buffer (Invitrogen) 
for 30 min at 60V and 90 min at 120V. The protein was transferred onto a 
 14
nitrocellulose membrane using the iBlot transfer system (Invitrogen). The membrane 
was incubated in Odyssey blocking buffer (LI-COR) for 1 h at 25°C before being 
incubated with a rabbit anti-mouse αSMA antibody (Abcam) at 2 µg/ml overnight at 
4°C followed by a goat anti-rabbit IRDye 800CW secondary antibody (LI-COR) at 0.2 
µg/ml for 45 min at 25°C. The membrane was then imaged on a LI-COR Odyssey 
CLx infrared imaging system. The blot was then re-probed for cytokeratin 14 (1 
µg/ml; Covance) following the same protocol. 
 
Statistical analysis 
Data are presented as the mean of independent experiments with SEM. 
Comparisons between multiple groups were analysed using analysis of variance 
(ANOVA) followed by Bonferroni post-tests. Comparisons between 2 groups were 
analysed using 2-tailed, 2-sample Student’s t-tests. Statistical significance was set at 
P < 0.05. All raw data can be found in the data source file. 
MRU frequencies between different cell populations were compared statistically 
using the Extreme Limiting Dilution Analysis (ELDA)36 online tool 
(http://bioinf.wehi.edu.aU/software/elda/).  
 
 






